Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Guanjun Cheng"'
Autor:
Susan Lanza-Jacoby, Guanjun Cheng
Publikováno v:
Pharmaceutical Biology, Vol 56, Iss 1, Pp 407-414 (2018)
Context: A major problem in the treatment of cancer is the development of toxic side effects and resistance to chemotherapy. The use of plant compounds to overcome resistance and prevent toxicity is a potential strategy for treatment. Objective: We e
Externí odkaz:
https://doaj.org/article/63abb313b5e54aadbcb7e615033e1b9b
Publikováno v:
Neurobiology of Disease, Vol 11, Iss 1, Pp 199-213 (2002)
Acid sphingomyelinase (ASMase) and NF-κB participate in tumor necrosis factor α (TNFα) signal transduction. Mice in which the genes encoding ASMase or the p50 subunit of NF-κB are disrupted have been reported to be less vulnerable than wild-type
Externí odkaz:
https://doaj.org/article/2f6ede74064f466f849ab9db1ab61c02
Autor:
Zvi G Fridlender, Jing Sun, Inbal Mishalian, Sunil Singhal, Guanjun Cheng, Veena Kapoor, Wenhwai Horng, Gil Fridlender, Rachel Bayuh, G Scott Worthen, Steven M Albelda
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31524 (2012)
The role of myeloid cells in supporting cancer growth is well established. Most work has focused on myeloid-derived suppressor cells (MDSC) that accumulate in tumor-bearing animals, but tumor-associated neutrophils (TAN) are also known to be capable
Externí odkaz:
https://doaj.org/article/1d5b9beda32c4d08a69d31ac68392541
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Table 1 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fbbc3752c3b5855e1c934f3154cc098
https://doi.org/10.1158/0008-5472.22382091
https://doi.org/10.1158/0008-5472.22382091
Autor:
Steven M. Albelda, Leona Ling, Larry R. Kaiser, Michael Corbley, Xiamei Zhang, Hung Kam Cheung, Andrew Haas, Guanjun Cheng, Veena Kapoor, Jing Sun, Zvi G. Fridlender, George Buchlis, Samuel Kim
Supplementary Table 1 from Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1370d3751a8e7cf12edf320ef70b611e
https://doi.org/10.1158/0008-5472.22376375.v1
https://doi.org/10.1158/0008-5472.22376375.v1
Autor:
Steven M. Albelda, Leona Ling, Larry R. Kaiser, Michael Corbley, Xiamei Zhang, Hung Kam Cheung, Andrew Haas, Guanjun Cheng, Veena Kapoor, Jing Sun, Zvi G. Fridlender, George Buchlis, Samuel Kim
Supplementary Figure 1 from Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427377f426aeadc2fd0811b7e7530d89
https://doi.org/10.1158/0008-5472.22376378.v1
https://doi.org/10.1158/0008-5472.22376378.v1
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Altering the immunosuppressive microenvironment that exists within a tumor will likely be necessary for cancer vaccines to trigger an effective antitumor response. Monocyte chemoattractant proteins (such as CCL2) are produced by many tumors and have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d86ae4e7e6dca427fffee9a7f8deaf
https://doi.org/10.1158/0008-5472.c.6500100.v1
https://doi.org/10.1158/0008-5472.c.6500100.v1
Autor:
Steven M. Albelda, Leona Ling, Larry R. Kaiser, Michael Corbley, Xiamei Zhang, Hung Kam Cheung, Andrew Haas, Guanjun Cheng, Veena Kapoor, Jing Sun, Zvi G. Fridlender, George Buchlis, Samuel Kim
Locally produced transforming growth factor-β (TGF-β) promotes tumor-induced immunosuppression and contributes to resistance to immunotherapy. This article explores the potential for increased efficacy when combining immunotherapies with TGF-β sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d41750078a79ff23a176960b72aced
https://doi.org/10.1158/0008-5472.c.6498182.v1
https://doi.org/10.1158/0008-5472.c.6498182.v1
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Figure Legend 1 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae781e96c8eecf3ed14b457838cbb0c
https://doi.org/10.1158/0008-5472.22382097
https://doi.org/10.1158/0008-5472.22382097
Autor:
Steven M. Albelda, Linda A. Snyder, Daniel Heitjan, Liang-Chuan S. Wang, M. Cecilia Crisanti, Sunil Singhal, Jing Sun, Guanjun Cheng, Veena Kapoor, George Buchlis, Zvi G. Fridlender
Supplementary Figure 1 from CCL2 Blockade Augments Cancer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6232dcc8cafe98805039dca7ef7c870c
https://doi.org/10.1158/0008-5472.22382103
https://doi.org/10.1158/0008-5472.22382103